AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38

Authors: NICHOLLS MG RICHARDS AM MOLLER PW ELLIOTT JM BEGG EJ
Citation: Mg. Nicholls et al., NEW GOVERNMENT, SAME NARROW VISION - HEALTH AUTHORITIES IN NEW-ZEALAND HAVE SPIN DOCTORS TO PRODUCE GOOD-NEWS, BMJ. British medical journal, 316(7140), 1998, pp. 1321-1321

Authors: MOLLER PW NICHOLLS MG BEGG EJ
Citation: Pw. Moller et al., UNSHACKLING THE HOSPITALS, New Zealand medical journal, 111(1071), 1998, pp. 305-305

Authors: MOLLER PQ BEGG EJ
Citation: Pq. Moller et Ej. Begg, DEATHS AT CHRISTCHURCH-HOSPITAL, New Zealand medical journal, 111(1068), 1998, pp. 237-237

Authors: MOLLER PW NICHOLLS MG BEGG EJ DONALD RA
Citation: Pw. Moller et al., HEALTH-CARE, FUNDING AND ORATORY, New Zealand medical journal, 111(1067), 1998, pp. 213-215

Authors: DUFFULL SB BEGG EJ ROBINSON BA DEELY JJ
Citation: Sb. Duffull et al., A SEQUENTIAL BAYESIAN ALGORITHM FOR DOSE INDIVIDUALIZATION OF CARBOPLATIN (VOL 39, PG 317, 1997), Cancer chemotherapy and pharmacology, 41(1), 1997, pp. 91-91

Authors: DUFFULL SB BEGG EJ ROBINSON BA DEELY JJ
Citation: Sb. Duffull et al., A SEQUENTIAL BAYESIAN ALGORITHM FOR DOSE INDIVIDUALIZATION OF CARBOPLATIN, Cancer chemotherapy and pharmacology, 39(4), 1997, pp. 317-326

Authors: SAUNDERS DA BEGG EJ KIRKPATRICK CMJ YEO J GRAHAM GG BAILEY RR
Citation: Da. Saunders et al., MEASUREMENT OF TOTAL PHOSPHOLIPIDS IN URINE OF PATIENTS TREATED WITH GENTAMICIN, British journal of clinical pharmacology, 43(4), 1997, pp. 435-440

Authors: DUFFULL SB KIRKPATRICK CMJ BEGG EJ
Citation: Sb. Duffull et al., COMPARISON OF 2 BAYESIAN APPROACHES TO DOSE-INDIVIDUALIZATION FOR ONCE-DAILY AMINOGLYCOSIDE REGIMENS, British journal of clinical pharmacology, 43(2), 1997, pp. 125-135

Authors: BAILEY RR BEGG EJ ROBSON RA LYNN KL SMITH AH CHAMBERS ST BARCLAY ML HORNIBOOK J
Citation: Rr. Bailey et al., PROSPECTIVE, RANDOMIZED, CONTROLLED-STUDY COMPARING 2 DOSING REGIMENSOF GENTAMICIN WITH ORAL CIPROFLOXACIN SWITCH THERAPY FOR ACUTE PYELONEPHRITIS, Kidney international, 51(4), 1997, pp. 1316-1316

Authors: KIRKPATRICK CMJ DUFFULL SB BEGG EJ
Citation: Cmj. Kirkpatrick et al., ONCE-DAILY AMINOGLYCOSIDE THERAPY - POTENTIAL OTOTOXICITY, Antimicrobial agents and chemotherapy, 41(4), 1997, pp. 879-879

Authors: PEARCE MJ BEGG EJ
Citation: Mj. Pearce et Ej. Begg, ENCOURAGING CONSENSUS COST-EFFECTIVE DRUG-THERAPY - 5 YEARS EXPERIENCE WITH A HOSPITAL DRUG UTILIZATION REVIEW PROGRAM, New Zealand medical journal, 110(1040), 1997, pp. 92-95

Authors: BEGG EJ DUFFULL SB KIRKPATRICK CM
Citation: Ej. Begg et al., SINGLE OR MULTIPLE DAILY DOSES OF AMINOGLYCOSIDES - EXPOSURE TO AMINOGLYCOSIDES SHOULD BE MONITORED DURING TREATMENT, BMJ. British medical journal, 313(7055), 1996, pp. 491-491

Authors: BEGG EJ
Citation: Ej. Begg, DISSENSION FROM THE DEEP SOUTH, Clinical pharmacokinetics, 30(2), 1996, pp. 180-180

Authors: BARCLAY ML BEGG EJ CHAMBERS ST PEDDIE BA
Citation: Ml. Barclay et al., THE EFFECT OF AMINOGLYCOSIDE-INDUCED ADAPTIVE RESISTANCE ON THE ANTIBACTERIAL ACTIVITY OF OTHER ANTIBIOTICS AGAINST PSEUDOMONAS-AERUGINOSA IN-VITRO, Journal of antimicrobial chemotherapy, 38(5), 1996, pp. 853-858

Authors: BARCLAY ML BEGG EJ CHAMBERS ST THORNLEY PE PATTEMORE PK GRIMWOOD K
Citation: Ml. Barclay et al., ADAPTIVE RESISTANCE TO TOBRAMYCIN IN PSEUDOMONAS-AERUGINOSA LUNG INFECTION IN CYSTIC-FIBROSIS, Journal of antimicrobial chemotherapy, 37(6), 1996, pp. 1155-1164

Authors: BAILEY RR BEGG EJ SMITH AH ROBSON RA LYNN KL CHAMBERS ST BARCLAY ML HORNIBROOK J
Citation: Rr. Bailey et al., PROSPECTIVE, RANDOMIZED, CONTROLLED-STUDY COMPARING 2 DOSING REGIMENSOF GENTAMICIN ORAL CIPROFLOXACIN SWITCH THERAPY FOR ACUTE PYELONEPHRITIS/, Clinical nephrology, 46(3), 1996, pp. 183-186

Authors: DUFFULL SB BEGG EJ ILETT KF
Citation: Sb. Duffull et al., FLUOXETINE DISTRIBUTION IN HUMAN-MILK, Journal of clinical pharmacology, 36(11), 1996, pp. 1078-1078

Authors: BEGG EJ NICHOLLS MG RICHARDS AM
Citation: Ej. Begg et al., THE MANAGEMENT OF MILDLY RAISED BLOOD-PRESSURE IN NEW-ZEALAND - AN ALTERNATIVE VIEW, New Zealand medical journal, 109(1024), 1996, pp. 237-240

Authors: BUSCH AF PEARCE MJ ALLEN B BEGG EJ
Citation: Af. Busch et al., COMPLIANCE WITH GUIDELINES RESULTS IN APPROPRIATE ONDANSETRON PRESCRIBING AT CHRISTCHURCH-HOSPITAL, New Zealand medical journal, 109(1020), 1996, pp. 142-144

Authors: MCLEOD SJ PEARCE MJ RIGBY SA BEGG EJ BEARD MEJ MARTIN IR DRENNAN CJ TOWN GI
Citation: Sj. Mcleod et al., ASTHMA MANAGEMENT AT CHRISTCHURCH-HOSPITAL - COMPLIANCE WITH GUIDELINES, New Zealand medical journal, 109(1019), 1996, pp. 115-118

Authors: BARCLAY ML DUFFULL SB BEGG EJ
Citation: Ml. Barclay et al., LIMITATIONS IN THE AREA-UNDER-THE-CURVE METHOD FOR PREDICTING DAILY DOSES OF GENTAMICIN - REPLY, Australian and New Zealand Journal of Medicine, 26(1), 1996, pp. 117-118

Authors: BEGG EJ BARCLAY ML
Citation: Ej. Begg et Ml. Barclay, AMINOGLYCOSIDES - 50 YEARS ON, British journal of clinical pharmacology, 39(6), 1995, pp. 597-603

Authors: BEGG EJ BARCLAY ML DUFFULL SB
Citation: Ej. Begg et al., A SUGGESTED APPROACH TO ONCE-DAILY AMINOGLYCOSIDE DOSING, British journal of clinical pharmacology, 39(6), 1995, pp. 605-609

Authors: DUFFULL SB BEGG EJ
Citation: Sb. Duffull et Ej. Begg, WHY MONITOR PEAK VANCOMYCIN CONCENTRATIONS, Lancet, 345(8950), 1995, pp. 646-646

Authors: BARCLAY ML BEGG EJ CHAMBERS ST BOSWELL DR
Citation: Ml. Barclay et al., IMPROVED EFFICACY WITH NONSIMULTANEOUS ADMINISTRATION OF FIRST DOSES OF GENTAMICIN AND CEFTAZIDIME IN-VITRO, Antimicrobial agents and chemotherapy, 39(1), 1995, pp. 132-136
Risultati: 1-25 | 26-38